Siddharth S. Menon

From targeted drug delivery to tissue regeneration: the evolving role of nanoparticle therapies in liver disease.

Chronic liver disease (CLD) cases are rising globally, impacting people across all age groups. The broad spectrum of etiologies and the heterogeneous presentation of CLDs make it challenging to develop effective therapeutic interventions. Current treatments focus on eliminating the underlying cause (e.g. in infections)...